Recent studies have revealed that GLP-1 medications, such as Ozempic, may have effects on the brain beyond their established roles in metabolism, hunger control, and blood sugar regulation.

A small study involving 13 young women showed notable changes in the salience network, a brain region associated with attention and focus, within just a few months of use.Researchers describe these findings as unexpected and caution that the implications are not yet fully understood.

Originally developed to address obesity and diabetes, GLP-1 drugs are now being investigated for their potential impact on mental health and addictive behaviors.

Early anecdotal reports suggest improvements in mood, reduced anxiety, and enhanced cognitive clarity, prompting scientists to consider whether these medications might influence reward, craving, and motivation pathways in the brain.Ongoing studies are examining their effects on nicotine, opioid, and cocaine dependence, gambling, and binge eating.

Experts emphasize that while these findings are promising, GLP-1 drugs are not currently approved for psychiatric or neurological treatment, and further research is needed to determine whether observed brain changes are beneficial, neutral, or potentially alter personality.